Description
Retatrutide 30mg (also referenced in research literature as LY3437943) is a synthetic triple-receptor laboratory research peptide designed for studies involving three key metabolic signaling pathways: GLP-1, GIP, and glucagon receptor activity.
In non-clinical settings, Retatrutide is commonly reviewed in laboratory studies connected to incretin signaling, metabolic pathway research, glucose-response models, energy-balance investigation, and multi-receptor interaction studies.
GLP-1 (glucagon-like peptide-1) receptor pathways are often researched for their role in incretin-related signaling and glucose-response models. GIP (glucose-dependent insulinotropic polypeptide) receptor activity is commonly studied in relation to nutrient-response signaling and metabolic regulation models. Glucagon receptor activity is frequently reviewed in laboratory studies involving energy expenditure models, hepatic signaling, and metabolic pathway behavior.
Together, these three receptor pathways make Retatrutide 30mg a key reference compound for researchers exploring triple-agonist peptide activity within controlled, non-clinical laboratory environments. It is supplied by Prestige Peptides in lyophilized vial format and is intended for qualified research use only. It is not positioned as a medicine, supplement, wellness product, fat-loss product, diabetes treatment, appetite-control product, or performance aid.
Research Context
Retatrutide 30mg may be of interest in laboratory studies focused on:
- Incretin pathway signaling
- GLP-1 receptor activity research
- GIP receptor activity research
- Glucagon receptor pathway studies
- Metabolic-response models
- Glucose-response pathway research
- Energy-balance investigation
- Multi-receptor peptide interaction studies
- Non-clinical metabolic research models
These references are provided for research context only and must not be understood as human benefit claims.
Chemical & Analytical Reference Specifications
| Specification | Reference Value |
|---|---|
| Compound Name | Retatrutide (LY3437943) |
| Catalogue SKU | PP-RET30 |
| CAS Registry Number | 2381089-83-2 |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | 4731.33 g/mol |
| Peptide Classification | 39-Amino-Acid Acylated Triple-Receptor Agonist (GLP-1R / GIPR / GCGR) |
| Purity Specification | ≥99% (HPLC & MS Verified) |
| Physical Form | Sterile Lyophilized Solid (Freeze-Dried Powder) |
| Net Content per Vial | 30 mg |
| Recommended Lab Storage | -20°C (Dry, dark laboratory freezer) |
| Dispatch & Fulfilment | Gauteng, South Africa (The Courier Guy Door or PUDO Locker) |
| Intended Use | In Vitro Laboratory Research Only (Not for Human Use) |
Related Research Compounds: Laboratories investigating metabolic and cellular energy signaling pathways also frequently examine MOTS-c 40mg and NAD+ 1000mg. Browse our full South African research peptides catalogue.
Important Notice
This product is supplied strictly for laboratory research purposes only. It is not intended for human or animal consumption, injection, topical use, medical treatment, diabetes management, weight-loss use, appetite control, performance enhancement, or any form of in vivo use.
Prestige Peptides does not provide dosing, usage, administration, application, or reconstitution guidance. Buyers are responsible for ensuring that this material is handled only within a suitable research environment and in line with applicable laws, safety standards, and internal laboratory procedures.
Reviews
There are no reviews yet.